GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: Forvisirvat is the INN for a sirtuin activator (WHO INN proposed list 133, July 2025). It is one of the compounds claimed in Sirtsei Pharmaceuticals' patent WO2021202822A1 [2]. The structure was disclosed as the sirtuin 6 activator clinical candidate SP-624 in early 2025, with suggested potential in psychiatric, neurodegenerative and metabolic disorders [3].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| (2S,5'R)-7-chloro-3',4-dimethoxy-5'-methyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1-benzofuran-2,4'-cyclohex-2-ene]-1',3-dione |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 13727 | forvisirvat |
Synonyms ![]() |
|
| Compound 1 [WO2024148149A2] [1] | DS-7830a [1] | SP-624 | SP624 | |
Database Links ![]() |
|
| CAS Registry No. | 2135638-06-9 (source: WHO INN record) |
| GtoPdb PubChem SID | 518520675 |
| PubChem CID | 131964504 |
| Search Google for chemical match using the InChIKey | MIHSWFYCAJWPIS-YLVJLNSGSA-N |
| Search Google for chemicals with the same backbone | MIHSWFYCAJWPIS |
| Search PubMed clinical trials | forvisirvat |
| Search PubMed titles | forvisirvat |
| Search PubMed titles/abstracts | forvisirvat |
| UniChem Compound Search for chemical match using the InChIKey | MIHSWFYCAJWPIS-YLVJLNSGSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | MIHSWFYCAJWPIS-YLVJLNSGSA-N |